Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Blood Test to Define Probability of Lung Nodule Being Cancer? Could Help, but Potential to Backfire
Author
Howard (Jack) West, MD

One of the challenges of the increased frequency of chest CT scans being done for screening of people at higher risk of lung cancer, or done more commonly for chest symptoms, is that lung nodules are very commonly found, but most the time they aren't cancer.  Most studies show that >90% of lung nodules are benign, but the majority lead to additional work-up, and in nearly 100% of cases, they cause anxiety for the patient. What if a blood test could help clarify the probability that someone doesn't have a lung cancer?

A recent paper from a highly respected group of researchers describes a new blood test called XPRESSYS that did a complex analysis of several hundred proteins to identity a 13-protein signature from a serum sample that assigns patients a favorable result associated with an extremely low probability of having lung cancer, so that a "negative" result was associated with a benign diagnosis 94% of the time. Importantly, a "positive"/"not negative" result was associated with only a 56% chance of the person having cancer, which is why the people developing the test that is now commercially available don't consider a result other than negative helpful, and they don't report it as a positive, but rather just negative or not.

Will this help? I must confess that I'm not confident it will.  It's a great idea -- being able to use a blood test to help clarify whether someone should be reassured about one or more lung nodules not being cancer is wonderful. The problem is that the company says that a result other than negative should be ignored, but that's far easier said than done.  In reality, people won't ignore a result that isn't negative, and I suspect that patients and doctors who see a result that isn't negative will escalate their anxiety and the pace of their workup even though only 50-60% of the people on the study who tested this way ended up having cancer. 

In other words, while the concept is great, it seems to me that the results are helpful if the test is negative, but harmful if the test comes back as "not negative",  and you can't just tell people to ignore results that make your test unhelpful.

What do you think? Would you NOT feel more anxious and want to move ahead faster with a workup if your test came back with a result other than negative?

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on